Latest Articles about LMNX

Luminex Collaborates with NMTC - Analyst Blog

Zacks Equity Research — Fri, 14 Jun 2013 17:20:01 Z

Diagnostic testing technologies company, Luminex Corporation ( LMNX ) has entered into a multi-year collaboration and license agreement with leading pharmacogenomic testing company Natural

Luminex and Merck KGaA Extend Ties - Analyst Blog

Zacks Equity Research — Fri, 31 May 2013 22:32:14 Z

Diagnostic testing technologies company, Luminex Corporation ( LMNX ) has renewed its agreement with Germany-based leading life science and protein research company, Merck KGaA. Under the

In Insider Trading, Tesla Motors Sees a Sale While MoSys CEO Buys Shares

Josh Wolonick — Tue, 21 May 2013 19:27:00 Z

Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside sales and purchases filed with the SEC on Monday, May 20, 2013. Purchases: Leonard Perham, the

BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector

Monica Wolfe — Tue, 14 May 2013 18:03:57 Z

In the past week we saw an increase in insider buying coming from the health care industry. Last week GuruFocus reported 31 different insider buys coming from 19 different health care-based

Luminex Beats 1Q Earnings Est. - Analyst Blog

Zacks Equity Research — Wed, 01 May 2013 13:47:17 Z

Luminex Corporation 's ( LMNX ) first-quarter 2013 adjusted earnings per share of 14 cents beat the Zacks Consensus Estimate of 8 cents per share by 75%. It also exceeded the year-ago

FDA Nod for Luminex Offering - Analyst Blog

Zacks Equity Research — Fri, 19 Apr 2013 22:10:10 Z

Diagnostic testing technologies company, Luminex Corporation ( LMNX ) has won clearance from the U.S. Food and Drug Administration for its MAGPIX instrument, with its xTAG Gastrointestinal

Merck-Luminex' Alzheimer's Collaboration - Analyst Blog

Zacks Equity Research — Wed, 20 Mar 2013 00:47:42 Z

Merck ( MRK ) recently entered into an agreement with Luminex Corporation ( LMNX ) for the development of a companion diagnostic device that will be used to screen patients for

Luminex Beats EPS, Profits Up - Analyst Blog

Zacks Equity Research — Tue, 05 Feb 2013 20:10:01 Z

Luminex Corporation 's ( LMNX ) fourth-quarter 2012 adjusted earnings of 12 cents per share (up 9% year over year) beat the Zacks Consensus Estimate of 10 cents per share. Adjusted earnings

Luminex Wins FDA Clearance - Analyst Blog

Zacks Equity Research — Thu, 17 Jan 2013 00:30:01 Z

Luminex Corporation ( LMNX ) recently revealed that it won clearance from the FDA for its xTAG Gastrointestinal Pathogen Panel, which is a complete molecule-based diagnostic assay. It tests

Luminex Retained at Neutral - Analyst Blog

Zacks Equity Research — Tue, 18 Dec 2012 21:30:01 Z

Luminex Corporation 's ( LMNX ) third quarter 2012 adjusted earnings of $0.04 per share missed the Zacks Consensus Estimate of $0.07 per share and the year-ago earnings of $0.05 per share.

Luminex Misses Ests., Trims Outlook - Analyst Blog

Zacks Equity Research — Tue, 30 Oct 2012 18:27:07 Z

Luminex Corporation 's ( LMNX ) third quarter 2012 adjusted (excluding one-time charges) earnings of 4 cents per share were lower than the Zacks Consensus Estimate of 7 cents per share as

Luminex Remains Neutral - Analyst Blog

Zacks Equity Research — Tue, 18 Sep 2012 00:34:36 Z

We reiterate our Neutral recommendation on Luminex Corporation ( LMNX ) following its second quarter results. In the reported quarter, adjusted (excluding one-time charges) earnings of 7

Luminex Wins Technology Award - Analyst Blog

Zacks Equity Research — Fri, 07 Sep 2012 20:15:01 Z

Diagnostic testing technologies company, Luminex Corporation ( LMNX ) recently received a Technology Award from the Austin Chamber of Commerce. The company has been recognized for its

Luminex Wins DTRA Contract - Analyst Blog

Zacks Equity Research — Sat, 11 Aug 2012 01:22:33 Z

Luminex Corporation ( LMNX ), a developer of biological testing technologies, recently announced that the Defense Threat Reduction Agency ("DTRA") has awarded the company with

Mixed 2Q for Luminex, Profit Dips - Analyst Blog

Zacks Equity Research — Tue, 31 Jul 2012 21:15:01 Z

Luminex Corporation ( LMNX ) reported second quarter 2012 adjusted (excluding one-time charges) earnings of 7 cents per share, in line with the Zacks Consensus Estimate but lower than the